REFERENCES
- Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676–92.
- Jansen NJ, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopul-monary bypass. Ann Thorac Surg 1992; 54: 744–748.
- Wei MX, Kuukasjarvi P, Laurikka J, Pehkonen E, Kaukinen S, Laine S, Tarkka M. Cytokine responses in low-risk CABG. Int J Ang 2001; 10: 27–30.
- Subramanian VA, Sani G, Benetti FJ, Calafiore AM. Minimally invasive coronary bypass surgery: a multi-center report of preliminary experience. Circulation. 1995; 92 Suppl I: 645.
- Gu YJ, Mariani MA, van Oeveren W, Grandjean JG, Boonstra PW. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1998; 65: 420–4.
- Buffolo EE, Gerola LR. Coronary artery bypass grafting without cardiopulmonary bypass through median sternotomy and minimally invasive pro-cedure. Int J Cardiol 1997; 62 Suppl: S89—S93.
- Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993; 56 Suppl: S92–6.
- Starnes HF Jr, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, Brennan MF. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988; 82: 1321–5.
- Sawa Y, Ichikawa H, Kagisaki K, Ohata T, Matsuda H. IL-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 1998; 116: 511–17.
- Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108: 626–35.
- Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. IL-8 release and neutrophil degranu-lation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234–41.
- Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269–76.
- Strüber M, Cremer JT, Gohrbandt B, Hagl C, Jankowski M, Volker B, Ruckoldt H, Martin M, Haverich A. Human cytokine responses to coron-ary artery bypass grafting with and without cardi-opulmonary bypass. Ann Thorac Surg 1999; 68: 1330–5.
- Wan S, Izzat MB, Lee TW, Wan IY, Tang NL, Yim AP. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg. 1999; 68: 52–7.
- Cremer J, Struber M, Wittwer T, et al. Morbidity of cardiopulmonary bypass and potential benefits of minimally invasive coronary surgery. Cor Eupopaeum 1997; 6: 164–7.
- Wan S, LeClerc JL, Vincent JL . Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676–92.